TITLE

Tourette Bozukluğunda İlaç Tedavisi

AUTHOR(S)
Ayraler Taner, Hande; Güney, Esra; Taner, Yasemen
PUB. DATE
March 2013
SOURCE
Current Approaches in Psychiatry / Psikiyatride Guncel Yaklasiml;2013, Vol. 5 Issue 2, p246
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Tourette disorder is a chronic neuropsychiatric disorder characterized by vocal and motor tics. The course of the disorder shows waxing and vaning pattern and symptoms adversely affect patients' quality of life. Patients use psychopharmacologic agents for long periods to control their symptoms during which they also struggle with drug related side effects. Clinicians face serious difficulties in controlling symptoms with psychopharmacological agents. Primarily alpha 2 receptor agonists and antipsychotic drugs have been used in the treatment of Tourette disorder. Risperidone and aripiprazole are the most commonly used new generation antipsychotics in the treatment. In addition there are contradictory findings regarding the use of dopamine agonists, tetrabenazine, topiramate, levatirasetame, and delta-9-tetrahydrocannabinol in these patients.
ACCESSION #
87645101

 

Related Articles

  • The effectiveness and safety of plum-blossom needle therapy for Tourette syndrome: study protocol for a randomized controlled trial. Jinna Yu; Yongming Ye; Shanshan Li; Jun Liu; Yanbing Zhai; Min Zhang; Zhishun Liu // Trials;Jul2015, Vol. 16 Issue 1, p1 

    Background: Previous studies have indicated that acupuncture can alleviate the symptoms of Tourette syndrome (TS), but the evidence is insufficient. Sofar, there have been no reports on plum-blossom needle therapy for TS. Here we present a protocol for a randomized controlled trial using...

  • Increased mortality among elderly patients with dementia using atypical antipsychotics. Singh, Sonal; Wooltorton, Eric // CMAJ: Canadian Medical Association Journal;8/2/2005, Vol. 173 Issue 3, p252 

    Discusses research being done on the use of atypical anti-psychotic drugs in the treatment of behavioral and psychological symptoms of dementia. Reference to a study by P. E. Lee, S. S. Freedman et al, published in the 2004 issue of the "British Medical Journal"; Incidence of death among...

  • A Risk-Benefit Assessment of Risperidone for the Treatment of Behavioural and Psychological Symptoms in Dementia. Zaudig, M. // Drug Safety;Sep2000, Vol. 23 Issue 3, p183 

    The importance of behavioural and psychological symptoms in dementia (BPSD) is increasingly being recognised. Symptoms such as verbal and physical aggression, agitation, sleep disturbances and wandering are common, cause great distress to caregivers and are likely to lead to institutionalisation...

  • Withdrawing neuroleptic treatment from people with dementia, does not result in a significant change their behaviour, psychiatric symptoms, or quality of life. Mawat, Donald // Evidence Based Mental Health;Nov2004, Vol. 7 Issue 4, p111 

    The article presents an answer to the clinical question related to the effects of withdrawing neuroleptic treatment from people with dementia on behavior, psychiatric symptoms and quality of life. The authors note that due to the sample size, the statistical power of this study is not great...

  • ATYPICAL ANTIPSYCHOTICS FOR TOURETTE SYNDROME.  // Journal of Neurology, Neurosurgery & Psychiatry;Aug2011, Vol. 82 Issue 8, p15 

    An abstract of the article "Atypical Antipsychotics for Tourette Syndrome," by A. Cavanna, A. Pierce, and H. E. Rickards is presented.

  • INITIAL TREATMENT RETENTION TO HABIT REVERSAL TRAINING IN TOURETTE SYNDROME. Cavanna, A. E.; Pilcher, F. // Journal of Neurology, Neurosurgery & Psychiatry;Oct2012, Vol. 83 Issue 10, p8 

    Objective Tourette syndrome (TS) is a chronic neuropsychiatric movement disorder characterised by multiple motor and one or more phonic tics, plus associated behavioural problems. Specific behavioural interventions, either alone or as an adjunct to pharmacological treatment, have been shown to...

  • Antipsychotika zur Behandlung neuropsychiatrischer Störungen bei Demenz. Gertz, H.-J.; Stoppe, G.; Müller-Oerlinghausen, B.; Schmidt, L.G.; Baethge, C.; Hiemke, C.; Lieb, K.; Bschor, T. // Der Nervenarzt;Mar2013, Vol. 84 Issue 3, p370 

    Antipsychotics, when used to treat neuropsychological symptoms associated with dementia, are associated with low effectiveness but a high risk of side effects. Some of these unwanted effects are severe and include an increased rate of cerebrovascular events and increased mortality. Although...

  • Quality of Life in Dementia. Naglie, Gary // Canadian Journal of Neurological Sciences;Mar2007 Supplement 1, Vol. 34, pS57 

    The article focuses on the assessment of the effectiveness of interventions for dementia by using quality of life (QOL) measures. Patient self-report, caregiver proxy report and observational assessment by trained observers were used to measure the quality of life of persons with dementia. QOL...

  • pimozide.  // Royal Society of Medicine: Medicines;2002, p440 

    The article presents information on pimozide which is an antipsychotic drug that is used to treat patients suffering from psychotic disorders, such as schizophrenia, hypochondriacal psychosis and paranoid psychosis. It can also be used to treat Gilles de la Tourette syndrome. Administration is...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics